Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth
August 19, 2026 |
Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board
LONDON & PHILADELPHIA, 19 August 2026 – Lucid Group, a leader in healthcare communications and commercialisation, today announced that Eric Muller has joined the agency as Chief Executive Officer. He will succeed CEO, and original DiD Agency founder Rick Sannem, who will transition to Strategic Advisor to the Board.
This transition comes as Lucid Group continues to grow its global footprint and reflects a deliberate step to assemble the talent to drive the company’s next phase of growth, while strengthening its ability to translate complex science into real-world impact.
“Lucid works across the full arc of product commercialisation, from the earliest stages of clinical development to market launch and on through to loss of exclusivity. Eric understands how hard it can be for great science to break through but also how to commercialise healthcare at scale,” said Dr Rod MacKenzie, CMG, Chair, Lucid Group Board. “Our Board is grateful for Rick’s vision and entrepreneurial stewardship that built Lucid’s culture of delivering client success and pleased that he will continue to support us as we enter our next chapter.”
For more than 20 years, Lucid Group has built its reputation on deep client relationships and a shared mission to transform lives by ensuring innovative medicine doesn’t stop at approval, but it reaches the patients who need it most. As an independent firm, Lucid delivers its range of services as a single team, which means the senior people who win an engagement stay on it, from pitch through delivery.
“Healthcare is entering a new era, driven by extraordinary advances in science, data, and technology. Clients increasingly need a partner that turns complexity into clarity and impact by bringing together scientific expertise, creativity, and strategy, along with the power of data and AI. As data multiplies and development accelerates, knowing which evidence matters and what creative output will persuade is the part that becomes critical,” said Eric Muller, Chief Executive Officer, Lucid Group. “That is the future of healthcare marketing, and it is where Lucid is positioned to lead. I am a builder at heart, and I came to Lucid to build a business that helps clinicians, patients, and caregivers make better decisions about the things that matter most.”
Eric is a highly experienced executive who has operated both commercially and in senior leadership positions across global healthcare commercialisation for more than 25 years. Most recently, Eric was Group President and Chief Operating Officer of Publicis Health and previously held roles including President of Digitas Health. He began his career at Grey Advertising in New York.
His immediate priorities centre on expanding talent, client partnerships as well as data and technological capabilities. The company aims to further attract the best people in the industry, while being the partner they trust to succeed and building the data and AI capability that enables Lucid’s science, strategy, and creative to travel further.
“Years ago, we made a deliberate decision to build an independent business that brings specialised commercialisation services together under one roof to best serve healthcare and pharma clients and that’s exactly what Lucid has become,” said Rick Sannem, Strategic Advisor to Lucid’s Board of Directors. “I’m proud of the culture and standard of excellence we’ve built, and Eric’s track record as a hands-on, transformative leader makes him the right person to lead Lucid into its next chapter of growth.”
About Lucid Group
Lucid Group, a global leader in healthcare communications and commercialisation, is driven by a mission to transform lives by bridging the gap between scientific discovery and patient impact. For life sciences organisations navigating their highest-stakes decisions, Lucid doesn’t just communicate science but ensures clients leave a lasting impact on the market and the patients they serve. Lucid brings together experts across Strategy Consulting, Scientific and Medical Communications, and Commercial Communications, fusing scientific rigour, strategic foresight, commercial ingenuity, creative storytelling, and deep human insight into an integrated force, powered by real-world evidence. This unique approach allows Lucid to uncover the deep-seated insight that governs stakeholder behaviour and anchors bold, behaviour-changing ideas, executed at key moments and accelerated by AI and technology. To learn more about Lucid Group, visit www.wearelucidgroup.com and LinkedIn.
Media Contacts:
Chris Dougherty
Elyse Cole
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Lucid Group: A Community of Purpose
In this month’s Pharmaceutical Marketing Europe, Lucid Group’s Chief People Officer, Angela Young, discusses the importance of bringing the company’s purpose to life so that its people feel connected to…
A magic milestone: Katherine’s 10-year workiversary
Katherine Duxbury recently celebrated the momentous and magical milestone of 10 years with Lucid Group – congratulations! Surprise virtual celebrations have been had and, while they were no replacement for…
Lucid Group – Let’s Start Talking
We can all help to transform the lives of those we touch by taking the time to talk and listen to one another. The power of conversation, sharing thoughts, worries…
My Journey Into MedComms #LucidLife
In NetworkPharma’s latest career guide for wannabe account managers, Tessa Rowland, Senior Account Executive, discusses her journey into the varied and fast-paced world of medical communications.
Lucid Group bolster its talent with a further twelve new starters for 2021
As if welcoming eight new graduates was not enough to bring some excitement to the start of the new year, Lucid Group has also welcomed a further twelve new employees…
The Lucid Group Futures Academy welcomes its 2021 cohort
This week Lucid welcomed its newest cohort of graduates onto the 2021 Futures Academy programme. The programme provides graduates with a 12-month structured medical writing training programme. It’s a chance…
Our People and their Growth are at the heart of #LucidLife
2020 has been a year like no other, in more ways than one. We wanted to shine a light on the good and great of 2020 and reflect on far…
Advance Outcomes named of the most innovative strategies of 2020 by PM360
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Lucid Group’s pioneering behaviour-change methodology, Advance OutcomesTM, as one of…
Lucid Group Evolve and Simplify its Brand Architecture
The current pandemic has forced many industries to find new ways of working. Within medical communications (medcomms), this has involved pivoting quickly towards a digital-first approach in order to optimise…
Laurence Bannister joins Lucid Group as its new Chief Commercial Officer
Laurence brings a track record of success from 22 years’ experience in pharmaceuticals/healthcare – across affiliate, regional and global commercial roles – with the last 9 years being at STEM…